Curated Resources — Prognosis and treatment of Zantac-related Cancer

This page collects vetted references on medical safety, regulatory guidance, and clinical background for anyone researching this topic.

Primary topic reference

Prognosis and treatment of Zantac-related Cancer — Background & Analysis

In-depth context and analysis on this topic for researchers and advocates.

U.S. Food and Drug Administration (FDA)

Reference: U.S. Food and Drug Administration (FDA)

Authoritative source for clinical, regulatory, and public-health background reading.

European Medicines Agency (EMA)

Reference: European Medicines Agency (EMA)

Authoritative source for clinical, regulatory, and public-health background reading.

MedlinePlus — Trusted Health Information

Reference: MedlinePlus — Trusted Health Information

Authoritative source for clinical, regulatory, and public-health background reading.